Journal article
Vaccine technologies against avian influenza: current approaches and new directions
Journal of biomedical nanotechnology, Vol.10(9), pp.2261-2294
09/2014
DOI: 10.1166/jbn.2014.1983
PMID: 25992457
Abstract
The potential epidemiological human pandemic resulting from highly pathogenic avian influenza (HPAI) H5N1 has been studied extensively since the identification of the virus in the Guangdong province of China. The majority of research has focused on the unique and severe histopathological lesions induced by the virus. The severe pathological presentation of these infections has also prompted interest in identifying preventive and therapeutic approaches against HPAI. The potential severity of a HPAI pandemic and the efforts to identify effective intervention strategies have led to many novel discoveries in vaccine and antiviral development that are critically examined in this review.
Details
- Title: Subtitle
- Vaccine technologies against avian influenza: current approaches and new directions
- Creators
- Kathleen A Ross - Iowa State UniversityLucas M Huntimer - Iowa State UniversityJulia E Vela RamirezJustin R AdamsSusan L Carpenter - Iowa State UniversityMarian L Kohut - Iowa State UniversityTatiana Bronich - Pharmaceutical ScienceRichard Webby - St. Jude Children's Research HospitalKevin L Legge - University of IowaSurya K Mallapragadal - Iowa State UniversityMichael J Wannemuehler - Iowa State UniversityBalaji Narasimhan - Iowa State University
- Resource Type
- Journal article
- Publication Details
- Journal of biomedical nanotechnology, Vol.10(9), pp.2261-2294
- DOI
- 10.1166/jbn.2014.1983
- PMID
- 25992457
- ISSN
- 1550-7033
- eISSN
- 1550-7041
- Language
- English
- Date published
- 09/2014
- Academic Unit
- Microbiology and Immunology; Pathology
- Record Identifier
- 9984186494802771
Metrics
54 Record Views